Stock page

Stevanato Group SpA (STVN)

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Quote snapshot

$18.23
Daily change: —
ExchangeNYSE
Updated2026-05-09T04:19:30.411596Z

Price chart

Price history

Name
Revenue
Cost Of Goods Sold
Gross Profit
Gross Margin %
Research Development
Selling General Admin Expense
Depreciation Depletion Amortization
Other Operating Expense
Total Operating Expense
Operating Income
Operating Margin
Interest Income
Interest Expense
Other Income Expense
Other Income Minority Interest
Other Net Income Loss
Ebit
Ebitda
Ebitda Margin
Pretax Income
Tax Provision
Tax Rate
Net Income Continuing Operations
Net Income Discontinued Operations
Net Income
Net Income Including Noncontrolling Interests
Is Preferred Dividends
Shares Outstanding
Eps Basic
Eps Diluted
Net Margin

SEC filings

Latest 10-K filing table

Date Form Accession Link